Insider filing · LYCA
Lycia Therapeutics, Inc.
LYCA · Healthcare · 3 filings in 24 months
ticker →
Venrock Healthcare Capital Partners III, L.P. bought $613K of Lycia Therapeutics (LYCA)
Executed Oct 28, disclosed Oct 30, 2 days later.
Value, as filed
$613K
23,804 sh across 3 lots
Executed
Oct 28
the trade date, as filed
Disclosed
Oct 30
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
VP
Venrock Healthcare Capital Partners III, L.P.
10% owner
profile →
Venrock Healthcare Capital Partners III, L.P. (10% owner) filed 3 Form 4 reports as a reporting entity in the trailing twelve months (3 purchases, 0 sales), most often in Lycia Therapeutics, Inc. (LYCA). The largest single filing was $37.7M of LYCA (2,045,440 sh across 6 lots, as filed), executed Oct 23. The median gap between execution and disclosure was 2 days.
The name
LYCAHealthcare · Lycia Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics designed to degrade disease-cau…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Venrock Healthcare Capital Partners III, L.P. in LYCA
LYCAPURCHASE
Lycia Therapeutics, Inc.
$224K8,305 sh × $26.95
Exec Nov 2
Filed Nov 4 · 5:12 PM ET LYCAPURCHASE Lycia Therapeutics, Inc. $37.7M
2,045,440 sh across 6 lots
Exec Oct 23
Filed Oct 27 · 6:38 PM ET